Biota Pharmaceuticals Reports First Quarter Fiscal Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Biota Pharma (BOTA) Misses Q1 EPS by 8c
November 7, 2014 7:13 AM ESTBiota Pharma (NASDAQ: BOTA) reported Q1 EPS of ($0.20), $0.08 worse than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Biota Pharma (BOTA) click here.
... More